Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

ETH Zurich researchers used combined CRISPR techniques to reveal unknown cancer-related mutations in the EGFR gene, ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

The patents have been officially revoked following the pair's voluntary decision to withdraw them | Withdrawal follows ...

Life Sciences Center (LSC) have discovered a unique way for cells to silence specific genes without cutting DNA. This ...

Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA to proteins. But only two percent of the human genome actually encodes ...

The newest one is the self-revocation of two seminal CRISPR patents in Europe by the team led by two ... As a result, the ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Feng Zhang, 2021 Richard Lounsbery Award recipient, will present the 2024 Lounsbery Lecture on "Exploration of Biological ...

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...

These pioneering companies are transforming delivery, medicine, and space access--potentially creating massive opportunities for early investors.